Search for Clinical Trial Results
Kennedy Disease - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies Condition:
|
Recruiting |
Study Name: A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer Condition: Prostate Cancer Date: 2015-07-06 Interventions:
|
Not yet recruiting |
Study Name: Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer Condition:
|
Completed |
Study Name: Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women Condition:
|
Recruiting |
Study Name: Study of Hepatic Function in Patients With Spinal and Bulbar Muscular Atrophy Condition:
Date: 2014-04-25 |
Recruiting |
Study Name: Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers Condition: Salivary Cancer Date: 2016-04-21 Interventions: Drug: enzalutamide oral |
Withdrawn |
Study Name: STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling Condition: Adenocarcinoma of the Prostate Date: 2011-04-21 Interventions:
|
Recruiting |
Study Name: Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) Condition: Metastatic Breast Cancer Date: 2013-11-08 Interventions: Drug: Orteronel Other Name: Tak-700 |
Active, not recruiting |
Study Name: The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer Condition: Prostate Cancer Date: 2013-02-08 Interventions:
|
Recruiting |
Study Name: Phase II Trial of Enzalutamide for CRPC With Correlative Assessment of Androgen Receptor Signaling Condition: Prostate Cancer Date: 2013-09-04 Interventions: Drug: Enzalutamide Administration: 160 mg orally once dail |